Last edition
News about "PerkinElmer to acquire Nexcelom Bioscience"
PerkinElmer to acquire Nexcelom Bioscience for US$ 260 million
Nexcelom is a leading, global provider of automated cell counting instruments, image cytometry workstations, assays and a variety of cell reagents, consumables, and fit-for-purpose cell counting method selection and development instructions that follow ISO Cell Counting Standards and aid in the development of cell and gene and immuno-oncology therapies
PerkinElmer To Acquire Nexcelom Bioscience | 14/05/2021 | By Darshana | 199
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy